Form 4: AbbVie Director Brett J. Hart Reports Acquisition and Disposal of Common Stock

Director Brett J. Hart reports changes in beneficial ownership of AbbVie Inc. common stock, including the acquisition of restricted stock units and disposal of shares.

Summary

• On May 9, 2025, Brett J. Hart, a director of AbbVie Inc., reported transactions involving the company's common stock.
• Hart acquired 1,203 restricted stock units under the AbbVie Amended and Restated 2013 Incentive Stock Program.
• These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
• Hart also disposed of 19,472 shares of common stock.
• Following these transactions, Hart beneficially owns 1,203 shares.

Sentiment

Score: 5

Explanation: This is a routine regulatory filing reflecting stock transactions by a company director. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The restricted stock units will be paid out in shares of AbbVie common stock upon the earlier of separation from service, death, or a change in control, as defined in the AbbVie Amended and Restated 2013 Incentive Stock Program.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their transactions in company stock. It is a standard practice for directors and officers of publicly traded companies.

Stakeholder Impact

• The transactions reported may be of interest to shareholders as they provide insight into the actions of a company director.

Key Dates

Keywords

AbbVie, Director, Beneficial Ownership, Form 4, Restricted Stock Units, Common Stock, Hart, ABBV